30 Mg Octreotide For Injection

Name: 30 Mg Octreotide For Injection
Brand: NEETCO BIOPHARMA
Price: 12000 INR
Availability: InStock

Price 12000 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

30 Mg Octreotide For Injection Specification

Dosage Form
Lyophilized Powder for Injection

Indication
Treatment of acromegaly, neuroendocrine tumors, carcinoid syndrome and vasoactive intestinal peptide-secreting tumors (VIPomas)

Salt Composition
Octreotide Acetate

Enzyme Types
Non-Enzymatic (Peptide Analog of Somatostatin)

Feature
Long-acting formulation, sustained-release, single-dose vial

Ingredients
Each vial contains Octreotide Acetate 30 mg, Excipients Q.S.

Application
Intramuscular Injection

Ph Level
Approximately 4.0 to 5.0 after reconstitution

Temperature Needed For Fermentation
Not Applicable (Synthetic production)

Physical Color/Texture
White to off-white lyophilized cake or powder

Fermentation Smell
Odorless (Non-fermented)

Enzymatic Activity
Somatostatin analog activity, inhibits secretion of various hormones

Storage Instructions
Store below 25C, protect from light, do not freeze

Shelf Life
24 months from production date

About 30 Mg Octreotide For Injection

Experience elite value and enlightened healthcare with 30 Mg Octreotide For Injection-engineered to best suit advanced therapeutics for acromegaly, neuroendocrine tumors, and VIPomas. This customizable solution offers lowest price access, available in both generic and branded formats. Each single glass vial contains 30 mg Octreotide Acetate as a lyophilized powder, manufactured under cGMP guidelines. Specifically designed for intramuscular administration after reconstitution with the supplied sterile solvent, its long-acting, sustained-release effect ensures efficacy for up to four weeks per dose. Prescription only; available for distribution, export, and supply in India.

Elite Features and Advanced Mechanism

30 Mg Octreotide For Injection showcases extra features including prolonged hormone inhibition and sustained-release formulation. Used as a premium treatment for acromegaly, neuroendocrine tumors, and VIPomas, it empowers enlightened patient care through precise dosage, single-dose vials, and ingenious somatostatin analog activity-ensuring maximal therapeutic benefit with customizable administration frequency. The product's sophisticated design supports high-value outcomes and elite clinical versatility.

Packaging & Delivery Excellence

Delivered in a secure single glass vial with attached sterile solvent for speedy reconstitution, each pack undergoes strict quality control. Quick dispatch and express shipping options ensure timely supply across India's main domestic market and leading export markets worldwide. The packaging preserves product stability, safeguarding against light and temperature extremes, and guarantees freshness up to 24 months. Clients value our responsive distribution network and commitment to rapid order fulfillment.

FAQ's of 30 Mg Octreotide For Injection:

Q: How should 30 Mg Octreotide For Injection be administered for optimal results?

A: The medication should be given via the intramuscular route only, after diluting the lyophilized powder vial with the provided sterile solvent, following medical prescription guidelines.

Q: What conditions is this injection typically used to treat?

A: 30 Mg Octreotide For Injection is indicated for the treatment of acromegaly, neuroendocrine tumors, carcinoid syndrome, and VIPomas, helping regulate hormone secretion.

Q: When is the injection administered, and how long does a dose last?

A: It is generally administered once every four weeks, with each dose delivering a prolonged effect that lasts up to four weeks, due to its sustained-release properties.

Q: Where should the reconstituted product be stored if not used immediately?

A: If not administered immediately after reconstitution, the injection should be stored at 2-8C and must be used within 24 hours to maintain efficacy and safety.

Q: What is the process for reconstituting the vial before injection?

A: To prepare the injection, add the supplied sterile solvent to the single glass vial containing the lyophilized powder, mix gently until fully dissolved, then administer intramuscularly.